HK392A - Pharmaceutical formulations with controlled release of the active substance - Google Patents

Pharmaceutical formulations with controlled release of the active substance

Info

Publication number
HK392A
HK392A HK3/92A HK392A HK392A HK 392 A HK392 A HK 392A HK 3/92 A HK3/92 A HK 3/92A HK 392 A HK392 A HK 392A HK 392 A HK392 A HK 392A
Authority
HK
Hong Kong
Prior art keywords
active substance
controlled release
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
HK3/92A
Other languages
English (en)
Inventor
Othmar Zuger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of HK392A publication Critical patent/HK392A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK3/92A 1985-10-01 1992-01-02 Pharmaceutical formulations with controlled release of the active substance HK392A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK392A true HK392A (en) 1992-01-10

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
HK3/92A HK392A (en) 1985-10-01 1992-01-02 Pharmaceutical formulations with controlled release of the active substance

Country Status (20)

Country Link
KR (1) KR920008817B1 (de)
AT (1) AT402257B (de)
BE (1) BE905516A (de)
CA (1) CA1298784C (de)
CH (1) CH669524A5 (de)
DE (1) DE3632201C2 (de)
DK (1) DK170016B1 (de)
ES (1) ES2002508A6 (de)
FR (1) FR2589732B1 (de)
GR (1) GR862457B (de)
HK (1) HK392A (de)
HU (1) HU197201B (de)
IE (1) IE59589B1 (de)
IL (1) IL80182A (de)
LU (1) LU86615A1 (de)
NL (1) NL194822C (de)
NZ (1) NZ217732A (de)
PT (1) PT83456B (de)
SE (1) SE503222C2 (de)
SG (1) SG103391G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6855729B2 (en) * 2001-02-20 2005-02-15 Timothy G. Dinan Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
FR2589732A1 (fr) 1987-05-15
PT83456A (en) 1986-10-01
AT402257B (de) 1997-03-25
PT83456B (pt) 1989-05-12
CA1298784C (en) 1992-04-14
SE8604112D0 (sv) 1986-09-29
HUT44701A (en) 1988-04-28
IE862565L (en) 1987-04-01
HU197201B (en) 1989-03-28
LU86615A1 (fr) 1987-04-02
CH669524A5 (de) 1989-03-31
DK464686A (da) 1987-04-02
KR870003777A (ko) 1987-05-04
DK464686D0 (da) 1986-09-29
IL80182A (en) 1991-01-31
ATA260486A (de) 1996-08-15
SE8604112L (sv) 1987-04-02
NL194822C (nl) 2003-04-03
IE59589B1 (en) 1994-03-09
KR920008817B1 (ko) 1992-10-09
DK170016B1 (da) 1995-05-01
DE3632201A1 (de) 1987-04-02
NL194822B (nl) 2002-12-02
SG103391G (en) 1992-01-17
DE3632201C2 (de) 1997-05-07
GR862457B (en) 1987-01-29
ES2002508A6 (es) 1988-08-16
FR2589732B1 (fr) 1989-07-13
IL80182A0 (en) 1986-12-31
NZ217732A (en) 1990-07-26
BE905516A (fr) 1987-03-30
SE503222C2 (sv) 1996-04-22
NL8602370A (nl) 1987-05-04

Similar Documents

Publication Publication Date Title
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
GB2211413B (en) Pharmaceutical formulations comprising microcapsules
EP0282951A3 (en) Controlled release preparations of active materials
GB8502974D0 (en) Sustained release of active substance
GB8504099D0 (en) Physiologically active substances
GB8630870D0 (en) Active support substance
ZA853462B (en) Controlled release pharmaceutical preparations
IL74049A0 (en) Controlled release liquid dosage pharmaceutical formulations
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
IL79163A0 (en) 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
HK392A (en) Pharmaceutical formulations with controlled release of the active substance
HUT42679A (en) Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances
GB8801863D0 (en) Pharmaceutical formulations with controlled drug release
ZA867507B (en) Pharmaceutical formulations with controlled release of the active substance
AU6322686A (en) Pharmaceutical formulations with controlled release of the active substance
ZA86705B (en) Controlled release insecticide
ZA875937B (en) Pharmaceutical formulations comprising microcapsules
IE850071L (en) Controlled release pharmaceutical formulations
GB8603031D0 (en) Pharmaceutical formulations
IT8648494A0 (it) Formulazioni farmaceutiche a liberazione prolungata della sostanza attiva
HUT43925A (en) Insecticides comprising trihalogen-imidazole derivatives as active substance and process for preparing the active substances
EG17797A (en) Controlled release formulation
IL68779A0 (en) Pharmaceutical mixture with controlled release of active substance

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20060928